Table 1. Potential Embolic Sources Based on Criteria Proposed by the Cryptogenic Stroke/ESUS International Working Group.
Potential Embolic Source | No. (%) of Cases (nā=ā2163) |
---|---|
Minor-risk potential cardioembolic sourcesa | 209 (9.7) |
Mitral valve | |
Myxomatous valvulopathy with prolapse | 2 (0.1) |
Mitral annular calcification | 7 (0.3) |
Aortic valve | |
Aortic valve stenosis | 13 (0.6) |
Calcific aortic valve | 4 (0.2) |
Nonatrial fibrillation atrial dysrhythmias and stasis | |
Atrial asystole and sick sinus syndrome | 43 (2.0) |
Atrial high-rate episodes | 32 (1.5) |
Atrial appendage stasis with reduced flow velocities or spontaneous echodensities | 21 (1.0) |
Atrial structural abnormalities | |
Atrial septal aneurysm | 13 (0.6) |
Chiari network | 1 (0.0) |
Left ventricle | |
Moderate systolic or diastolic dysfunction, global or regional | 80 (3.7) |
Ventricular noncompaction | 0 |
Endomyocardial fibrosis | 0 |
Covert paroxysmal atrial fibrillation | 43 (2.0) |
Cancer associated | 79 (3.7) |
Covert nonbacterial thrombotic endocarditis | 79 (3.7) |
Tumor emboli from occult cancer | 0 |
Arteriogenic embolia | 522 (24.1) |
Aortic arch atherosclerotic plaques | 520 (24.0) |
Carotid artery nonstenotic plaques with ulceration | 4 (0.2) |
Paradoxical embolism | 190 (8.8) |
Patent foramen ovale | 168 (7.8) |
Atrial septal defect | 10 (0.5) |
Pulmonary arteriovenous fistula | 12 (0.6) |
Undetermined embolism | 1120 (51.8) |
Multiple embolic sourcesb | 198 (9.2) |
Undetermined sourcec | 922 (42.6) |
Abbreviation: ESUS, embolic stroke of undetermined source.
Patients with 2 or more potential embolic sources of minor-risk potential cardioembolic sources or arteriogenic emboli were included in the minor-risk potential cardioembolic sources or arteriogenic emboli group, respectively.
Patients with 2 or more potential embolic sources of different etiologies were categorized as patients with multiple embolic sources in the undetermined embolism group.
Patients whose potential cause could not be identified were categorized as patients with undetermined source in the undetermined embolism group.